European Society for Vascular Surgery

Translational meeting

7-8 June 2022, Stockholm, Sweden

 

Translational science – from bench to bedside ↓

 

Limb ischaemia – from pathophysiology to clinic

 

This meeting aims to merge basic researchers, physicians and industry to give scientific updates on burning issues.

 

Oral abstract presentations and posters with Young Investigator Awards

 

in collaboration with

 and 

 

REGISTRATION

Click on your category on the right

 

Accommodation

ESVS has blocked rooms in the closest hotel to the venu: Carolina Elite Hotel

Venue

Bioclinicum

Auditorium Sune Bergstrom

Solnavägen 30

171 64 Solna

Sweden

Sponsors

If you are a medical company, join us onsite as an exhibitor!

Social Event

The City Hall of Stockholm and the Region of Stockholm invite all participants for a networking evening.

If you are interested, please book your free ticket: the names of all participants need to be communicated to the City Hall in advance

Transport

Taxi, bus, train… You have many options to reach the venue.

TAXI: 31mn / 45€

FLYGBUSSARNA BUS: 31mn / 12€ (stop at Karolinska Sjukhuset Eugeniavägen)

TRAIN+BUS: 50mn / (Arlanda Express + 3 > stop at Karolinska Sjukhuset Eugeniavägen)

Accreditation

The ESVS Translational Meeting, taking place from 7th to 8th June, 2022 in Stockholm, Sweden has been granted 10 European CME credits (ECMEC®s) by the European Accreditation Council for
Continuing Medical Education (EACCME®).

 PROGRAMME

Tuesday, 7th June 2022

12:00-12:05 Welcome address  
Session 1: CLTI – the deadly CVD partner
12:05  Clinical introduction – the Unmet needs : Health impact of CLTI Birgitta Sigvant, Sweden
12:20 Keynote lecture: Thearpeutic advances in CVD treatment Nick Leeper, USA
12:50 Genetics of muscle inflammation in chronic limb-threatening ischemia: The TNF-α hypothesis Diego Caicedo Valdés, Spain
13:05 Vein Bypass versus Nitinol Stent in Long Femoropopliteal Lesions. 4-Year Results of a Randomized Controlled Trial Florian Enzmann, Austria
13:20 Proprotein Convertase Subtilisin/Kexin Type 6 (PCSK6) plays a Role in Angiogenesis Regulation Melody Chemaly, Sweden
13:35 Arterial vs. venous cytokine profile in patients with LEAD Riikka Tulamo, Finland
13.50 Gender related differences in chronic limb threatening ischemia due to femoro-popliteal disease Laura Yáñez García, Spain
14.05 Panel Discussion  
14:15-15:15 Coffee break & poster viewing  
Session 2: From bad to worse – ALI in the pandemic
15:15 Clinical introduction – the Unmet needs: COVID-19 and ALI IRL Christian-Alexander Behrendt, Germany
15:30 Keynote lecture:COVID-19 and vascular dysfunction Christer Betzholtz, Sweden
16:00 COVID-19 infection and acute mesenteric ischemia Tina Cohnert, Austria
16:30 The influence of gut microbiome metabolites on endothelial junction integrity – implications for aortic dissection? Thorsten Eierhoff, Germany
16:45 Panel discussion
17:00 – 18:00 Poster viewing  
19:00 City hall banquet  
 

,

Wednesday, 8th June 2022
Session 3: Mitigating failure after CLTI treatment
08:00 Clinical introduction – the Unmet needs : Clinical aspects on CLTI reconstrcution failure Joe Mills,USA
08:15 Keynote lecture: The pathophysiology of lower limb atherosclerosis Aloke Finn, USA
08:45 Determining the mechanism and safety of vessel preparation devices in calcified tibial arteries with histologic validation Trisha Roy, USA
09:00 Cystathionine gamma lyase (CGL) enzyme activity is crucial in hindlimb ischemia recovery through NAD-dependent mechanisms Kevin Kiesworo, Switzerland
09:15 Sodium Thiosulfate, a source of Hydrogen Sulfide, promotes angiogenesis and revascularization via metabolic reprogramming of endothelial cells. Florent Allagnat, Switzerland
09:30 Panel Discussion
10:00-11:00 Coffee break & poster viewing
Session 4: The worst of the worst-Diabetic CLTI
11:00 Clinical introduction – the Unmet needs: The clinical manifestations of diabetic CLTI Florian Dick, Switzerland
11:15 Keynote lecture:The pathophysiology behind diabetic vasculopathy and CLTI Kathryn Gallagher, USA
11:45 Calcification and inflammation related pathways are induced in atherosclerotic plaques of diabetic patients Glykeria Karadimou, Sweden
12:00 Evaluation of microcirculatory changes before and after endovascular intervention using a new multimodal imaging system Sofie Aronsson, Sweden
12:15 Evaluation of the angiosome concept using near-infrared fluorescence with indocyanine green. Bien Ferrari, Netherlands
12:30 Microcirculation assessment of the foot using laser speckle contrast imaging during endovascular and hybrid revascularisation procedures in patients with chronic limb threatening ischemia Bryan Wermelink, Netherlands
12:45 Near-infrared fluorescence with indocyanine green to predict clinical outcome after revascularization. Floris Tange, Netherlands
13:00 Panel discussion  
13:15-14:15 Lunch & poster viewing  
Session 5:Emerging horizons in CLTI management 
14:15 Clinical introduction – the Unmet needs:Recent clinical developments Joakim Nordanstig, Sweden
14.30 Keynote lecture:CLTI R&D  Nabil Chakfé, France
15.00 Fibrin-based bioartificial blood vessels – The journey towards a biologically active vascular prosthesis for peripheral revascularization Florian Helms, Germany 
15.15 Vascular grafts collagen coating resorption and healing process in humans Salomé Kuntz, France
15:30 Creation of  functional autologous arteriovenous fistulae in a large animal model using a synthetic biodegradable graft Paul J. Besseling, Netherlands
15:45 Leukocyte- and platelet rich fibrin (L-PRF) as a treatment of refractory vascular ulcers: first results of a prospective cohort study. Dries Dorpmans, Belgium
16:00 Panel discussion & prize ceremony  
16:15 Adjourn  
Feedback E-Library
Give us your feedback about our E-Library !
How would you rate your experience?
Do you have any additional comment?
Submit
Thank you for submitting your feedback!